论文信息 - Abstract CT050: A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors - 字舞流文

Abstract CT050: A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors

J. Schellens | J. Tabernero | M. Alsina | A. Huitema | M. Throsby | B. Doger | V. Boni | E. Calvo | R. Doornbos | C. Geuijen | S. Shamsili | Lex B H Bakker | K. Bol | M. Westendorp | A. D. Vries-Schultink